Intravitreal bevacizumab alters type IV collagenases and exacerbates arrested alveologenesis in the neonatal rat lungs

References

• Shah PK, Narendran V, Tawansy KA, Raghuram A, Narendran K. Intravitreal bevacizumab (Avastin) for post laser anterior segment ischemia in aggressive posterior retinopathy of prematurity. Indian J Ophthalmol. 2007;55:75–76.
   Google Scholar
• Mintz-Hittner HA, Kennedy KA, Chuang AZ. BEAT-ROP cooperative group. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. New England Journal of Medicine. 2011;364:603–615.
   Google Scholar
• Mintz-Hittner HA. Treatment of retinopathy of prematurity with vascular endothelial growth factor inhibitors. Early Hum Dev. 2012;88:937–941.
   Google Scholar
• Hård AL, Hellström A. On safety, pharmacokinetics and dosage of bevacizumab in ROP treatment – a review. Acta Paediatr. 2011;100:1523–1527.
   Google Scholar
• Le Cras TD, Markham NE, Tuder RM, Voelkel NF, Abman SH. Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure. Am J Physiol Lung Cell Mol Physiol. 2002;283:L555–L562.
   Google Scholar
• Gerber HP, Hillan KJ, Ryan AM, Kowalski J, Keller GA, Rangell L, et al. VEGF is required for growth and survival in neonatal mice. Development. 1999;126:1149–1159.
   Google Scholar
• Galambos C, Ng YS, Ali A, Noguchi A, Lovejoy S, D'Amore PA, et al. Defective pulmonary development in the absence of heparin-binding vascular endothelial growth factor isoforms. Am J Respir Cell Mol Biol. 2002;27:194–203.
   Google Scholar
• Kumar VH, Ryan RM. Growth factors in the fetal and neonatal lung. Front Biosci. 2004;9:464–480.
   Google Scholar
• Tambunting F, Beharry KDA, Waltzman J, Modanlou HD. Lung vascular endothelial growth factor signaling is impaired in extremely premature baboons developing bronchopulmonary dysplasia/chronic lung disease. J Investig Med. 2005;5:1–11.
   Google Scholar
• Doyle LW, Ford G, Davis N. Health and hospitalizations after discharge in extremely low birth weight infants. Semin Neonatol. 2003;8:137–145.
   Google Scholar
• Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163:1723–1729.
   Google Scholar
• Hasan J, Beharry KD, Valencia AM, Strauss A, Modanlou HD. Soluble vascular endothelial growth factor receptor 1 in tracheal aspirate fluid of preterm neonates at birth may be predictive of bronchopulmonary dysplasia/chronic lung disease. Pediatrics. 2009;123:1541–1547.
   Google Scholar
• Massova I, Kotra LP, Fridman R, Mobashery S. Matrix metalloproteinases: structure evolution and diversification. Federation of American Societies for Experimental Biology. 1998;12:1075–1095.
   Google Scholar
• Fukuda Y, Ishizaki M, Kudoh S, Kitaichi M, Yamanaka N. Localization of matrix metalloproteinases-1, −2, and −9, and tissue inhibitor of metalloproteinases −2 in interstitial lung diseases. Lab Invest. 1998;78:687–698.
   Google Scholar
• Matrisan LM. The matrix-degrading metalloproteinases. Bioessays. 1992;14:455–463.
   Google Scholar
• Woessner Jr J. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. Federation of American Societies for Experimental Biology. 1991;5:2145–2154.
   Google Scholar
• Hu J, Chen C, Su Y, DU J, Qian X, Jin Y. Vascular endothelial growth factor promotes the expression of cyclooxygenase 2 and matrix metalloproteinases in Lewis lung carcinoma cells. Exp Ther Med. 2012;4:1045–1050.
   Google Scholar
• Baker AH, Zaltsman AB, George SJ, Reuby AC. Divergent effects of tissue inhibitor of metalloproteinases-1, −2, or-3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. J Clin Invest. 1998;101:1478–1487.
   Google Scholar
• Katzentein AL, Myers JL. Idiopathic pulmonary fibrosis. Clinical relevance of pathologic classification. Am J Respir Crit Care Med. 1998;157:1301–1315.
   Google Scholar
• Crouch E. Pathobiology and pulmonary fibrosis. Am J Physio Lung Cell Mol Physiol. 1990;259:L159–L184.
   Google Scholar
• Raghu G, Striker L, Hudson LD, Striker GE. Extracellular matrix in normal and fibrotic lungs. Am Rev Respir Dis. 1985;131:281–289.
   Google Scholar
• Gomez D, Alonzo D, Yoship U, Thorgeinsson P. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol. 1997;74:111–122.
   Google Scholar
• Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, De Carlo A, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med. 1993;4:197–250.
   Google Scholar
• Seiki M. Membrane-type matrix metalloproteinases. Acta Pathalogica, Microbiologica, et Immunologica Scandinavica. 1999;107:137–143.
   Google Scholar
• Di Fiore JM, Martin RJ, Gauda EB. Apnea of prematurity-perfect storm. Respir Physiol Neurobiol. 2013;189:213–222.
   Google Scholar
• Singer L, Martin RJ, Hawkins SW, BensonSzekely LJ, Yamashita TS, Carlo WA. Oxygen desaturation complicates feeding in infants with bronchopulmonary dysplasia after discharge. Pediatrics. 1992;90:380–384.
   Google Scholar
• Di Fiore JM, Kaffashi F, Loparo K, et al. The relationship between patterns of intermittent hypoxia and retinopathy of prematurity in preterm infants. Pediatr Res. 2012;72:606–612.
   Google Scholar
• Morin J, Luu TM, Superstein R, Ospina LH, Lefebvre F, Simard MN, et al. Canadian neonatal network and the Canadian neonatal follow-up network investigators. neurodevelopmental outcomes following bevacizumab injections for retinopathy of prematurity. Pediatrics. 2016;137(4):e20153218.
   Google Scholar
• Coleman R, Beharry KD, Brock RS, Abad-Santos P, Abad-Santos M, Modanlou HD. Effects of brief clustered versus dispersed hypoxiv episodes on systemic and ocular growth factors in a rat model of OIR. Pediatr Res. 2008;64:50–55.
   Google Scholar
• Brock RS, Gebrekristos BH, Kuniyoshi KM, Modanlou HD, Falcao MC, Beharry KD. Biomolecular effects of JB1 (an IGF-I peptide analog) in a rat model of oxygen-induced retinopathy. Pediatr Res. 2011;69:35–41.
   Google Scholar
• Beharry KD, Cai CL, Sharma P, et al. Hydrogen peroxide accumulation in the choroid during intermittent hypoxia increases risk of severe oxygen-induced retinopathy in neonatal rats. Investigative Ophthalmology and Visual Science. 2013;54:7644–7657.
   Google Scholar
• Chang M, Bany-Mohammed F, Kenney MC, Beharry KD. Effects of a superoxide dismutase mimetic on biomarkers of lung angiogenesis and alveolarization during hyperoxia with intermittent hypoxia. Am J Transl Res. 2013;5:594–607.
   Google Scholar
• Jivabhai-Patel S, Bany-Mohammed F, McNally L, et al. Exogenous superoxide dismutase mimetic without scavenging H2O2 causes photoreceptor damage in a rat model for oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 2015;56:1665–1677.
   Google Scholar
• Tu C, Beharry KD, Shen X, et al. Proteomic profiling of the retinas in a neonatal rat model of oxygen-induced retinopathy with a reproducible ion-current-based MS1 approach. J Proteome Res. 2015;14:2109–2120.
   Google Scholar
• Aranda JV, Cai CL, Ahmad T, Bronshtein V, Sadeh J, Valencia GB, et al. Pharmacologic synergism of ocular ketorolac and systemic caffeine citrate in rat oxygen-induced retinopathy. Pediatr Res. 2016;80(4):554–565.
   Google Scholar
• Berkowitz BA, Kowluru RA, Frank RN, Kern TS, Hohman TC, Prakash M. Subnormal retinal oxygenation response precedes diabetic-like retinopathy. Invest Ophthalmol Vis Sci. 1999;40:2100–2105.
   Google Scholar
• Romano MR, Biagioni F, Besozzi G, Carrizzo A, Vecchione C, Fornai F, et al. Effects of bevacizumab on neuronal viability of retinal ganglion cells in rats. Brain Res. 2012;1478:55–63.
   Google Scholar
• Johnsen-Soriano S, Arnal E, Sancho-Tello M, Muriach M, Almansa I, Bosch-Morell F, et al. Intravitreal injection of bevacizumab induces inflammatory alterations in a uveitis experimental model. Eur J Ophthalmol. 2011;21:427–433.
   Google Scholar
• Burri PH. The postnatal growth of rat lung: 111. Morphology Anat Rec. 1974;180:77–98.
   Google Scholar
• Burri PH. Postnatal development and growth. In: Crystal RG, West JB, Barnes PJ, Weibel ER, eds. The Lung: Scientific Foundations (2nd Ed.). Philadelphia, PA: Lippincott-Raven; 1997:1013–1034.
   Google Scholar
• Atkinson JJ, Senior RM. Matrix metalloproteinase-9 in lung remodeling. Am J Respir Cell Mol Biol. 2003;28:12–24.
   Google Scholar
• Chakrabarti S, Patel KD. Matrix metalloproteinase-2 (MMP-2) and MMP-9 in pulmonary pathology. Exp Lung Res. 2005;31:599–621.
   Google Scholar
• Selman M, Ruiz V, Cabrera S, Segura L, Ramírez R, Barrios R, et al. TIMP-1, −2, −3, and −4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment? Am J Physiol Lung Cell Mol Physiol. 2000;279:L562–L574.
   Google Scholar
• Arden MG, Adamson IYR. Collagen degradation during postnatal lung growth in rats. Pediatr Pulmonol. 1992;14: 95–101.
   Google Scholar
• Arden MG, Spearman MA, Adamson IYR. Degradation of type IV collagen during the development of fetal rat lung. Am J Respir Cell Mol Biol. 1993;9:99–105.
   Google Scholar
• Danan C, Jarreau P-H, Franco M-L, Dassieu G, Grillon C, Alsamad A, et al. Gelatinase activities in the airways of premature infants and development of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol. 2002;283:L1086–L1093.
   Google Scholar
• Weiss SJ. Tissue destruction by neutrophils. N Engl J Med. 1989;320:365–376.
   Google Scholar
• Valencia AM, Beharry KD, Ang JG, Devarajan K, Van Woerkom R, Abrantes M, et al. Early postnatal dexamethasone influences matrix metalloproteinase-2 and −9, and their tissue inhibitors in the developing rat lung. Pediatr Pulmonol. 2003;35:456–462.
   Google Scholar
• Tambunting F, Beharry KD, Hartleroad J, Waltzman J, Stavitsky Y, Modanlou HD. Increased lung matrix metalloproteinase-9 levels in extremely premature baboons with bronchopulmonary dysplasia. Pediatr Pulmonol. 2005;39:5–14.
   Google Scholar
• Fukunaga S, Ichiyama T, Maeba S, Okuda M, Nakata M, Sugino N, et al. MMP-9 and TIMP-1 in the cord blood of premature infants developing BPD. Pediatr Pulmonol. 2009;44:267–272.
   Google Scholar
• Ekekezie II, Thibeault DW, Simon SD, Norberg M, Merrill JD, Ballard RA, et al. Low levels of tissue inhibitors of metalloproteinases with a high matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio are present in tracheal aspirate fluids of infants who develop chronic lung disease. Pediatrics. 2004;113:1709–1714.
   Google Scholar
• Cederqvist K, Sorsa T, Tervahartiala T, Maisi P, Reunanen K, Lassus P, et al. Matrix metalloproteinases-2, −8, and −9 and TIMP-2 in tracheal aspirates from preterm infants with respiratory distress. Pediatrics. 2001;108:686–692.
   Google Scholar
• Schulz CG, Sawicki G, Lemke RP, Roeten BM, Schulz R, Cheung PY. MMP-2 and MMP-9 and their tissue inhibitors in the plasma of preterm and term neonates. Pediatr Res. 2004;55:794–801.
   Google Scholar
• Bar-Or A, Nuttall RK, Duddy M, Alter A, Kim HJ, Ifergan I, Pennington CJ, et al. Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis. Brain. 2003;126:2738–2749.
   Google Scholar
• Ochs RH, Fischman AP. Depositional diseases of the lungs. In: Fishman AP, Elias JA, Grippi MA, eds. Fishman's Pulmonary Diseases and Disorders (3rd Ed.). New York, NY: McGraw-Hill; 1998, Chap. 75:1151–1161.
   Google Scholar
• Fredriksson K, Liu XD, Lundahl J, Klominek J, Rennard SI, Skold CM. Red blood cells increase secretion of matrix metalloproteinases from human lung fibroblasts in vitro. Am J Physiol Lung Cell Mol Physiol. 2006;290:L326–L333.
   Google Scholar
• Altshuler ME, Penn AH, Yang JA, Kim G-R, Schmid-Schönbein GW. Protease activity increases in plasma, peritoneal fluid, and vital organs after hemorrhagic shock in rats. PLOS ONE. 2012;7:e32672.
   Google Scholar
• Sweet DG, Curley AE, Chesshyre E, Pizzotti J, Wilbourn MS, Halliday HL, Warner JA. The role of matrix mealloproteinases-9 and −2 in development of neonatal chronic lung disease. Acta Paediatr. 2004;93:791–796.
   Google Scholar
• Hiratsuka S, Nakamura K, Iwai S, Murakami M, Itoh T, Kijima H, et al. MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell. 2002;2:289–300.
   Google Scholar
• Baker AH, Zaltsman AB, George SJ, Newby AC. Divergent effects of tissue inhibitor of metalloproteinase-1, −2, or −3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. J Clin Invest. 1988;101:1478–1487.
   Google Scholar
• Gómez D, Alonso D, Yoshiji U, Thorgeirsson P. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol. 1997;74:111–122.
   Google Scholar
• Guedez L, Stetler-Stevenson WG, Wolff L, Wang L, Fukushima P, Mansoor A, et al. In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1. J Clin Invest. 1998;102:2002–2010.
   Google Scholar
• Dik WA, van Kaam AH, Dekker T, et al. Early increased levels of matrix metalloproteinase-9 in neonates recovering from respiratory distress syndrome. Biol Neonat. 2006;89:6–14.
   Google Scholar
• Chetty A, Cao G-J, Severgnini M, et al. Role of matrix metalloprotease-9 in hyperoxic injury in developing lung. Am J Physiol Lung Cell Mol Physiol. 2008;295:L584–L592.
   Google Scholar
• Lukkarinen H, Hogmalm A, Lappalainen U, Bry K. Matrix metalloproteinase-9 deficiency worsens lung injury in a model of bronchopulmonary dysplasia. Am J Respir Cell Mol Biol. 2009;41:59–68.
   Google Scholar
• Hosford G, Fang X, Olson DM. Hyperoxia decreases matrix metalloproteinase-9 and increases tissue inhibitor of matrix metalloproteinase-1 protein in the newborn rat lung: association with arrested alveolarization. Pediatr Res. 2004;56:26–34.
   Google Scholar
• Gill SE, Huizar I, Bench EM, Sussman SW, Wang Y, Khokha R, et al. Tissue inhibitor of metalloproteinases 3 regulates resolution of inflammation following acute lung injury. Am J Pathol. 2010;176:64–73.
   Google Scholar
• Gill SE, Gharib SA, Bench EM, Sussman SW, Wang RT, Rims C, et al. Tissue inhibitor of metalloproteinases-3 moderates the proinflammatory status of macrophages. Am J Respir Cell Mol Biol. 2013;49:768–777.
   Google Scholar
• Gill SE, Pape MC, Khokha R, Watson AJ, Leco KJ. A null mutation for tissue inhibitor of metalloproteinases-3 (Timp-3) impairs murine bronchiole branching morphogenesis. Dev Biol. 2003;261:313–323.
   Google Scholar
• Elias GJ, Ioannis M, Theodora P, Dimitrios PP, Despoina P, Kostantinos V, et al. Circulating tissue inhibitor of matrix metalloproteinase-4 (TIMP-4) in systemic sclerosis patients with elevated pulmonary arterial pressure. Mediators Inflamm. 2008;2008:164134.
   Google Scholar
• Thurlbeck WM. Lung growth and development. In: Thulbeck WM, Chung AM, eds. Pathology of the Lung (2nd Ed). New York, NY: Thieme Medical Publishers; 1995:37–87.
   Google Scholar
• D'Angio CT, Maniscalco WM. The role of vascular growth factors in hyperoxia-induced injury to the developing lung. Front Biosci. 2002;7:d1609–d1623.
   Google Scholar
• Bhandari V. Disruption of lung microvascular development. In: Abman SH, ed. Bronchopulmonary Dysplasia. New York, NY: Informa Healthcare; 2010:146–166.
   Google Scholar
• Bhatt AJ, Pryhuber GS, Huyck H, Watkins RH, Metlay LA, Maniscalco WM. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;164:1971–1980.
   Google Scholar
• Abman SH. Impaired vascular endothelial growth factor signaling in the pathogenesis of neonatal pulmonary vascular disease. Adv Exp Med Biol. 2010;661:323–335.
   Google Scholar
• Been JV, Debeer A, van Iwaarden JF, Kloosterboer N, Passos VL, Naulaers G, et al. Early alterations of growth factor patterns in bronchoalveolar lavage fluid from preterm infants developing bronchopulmonary dysplasia. Pediatr Res. 2010;67:83–89.
   Google Scholar
• Tang JR, Karumanchi SA, Seedorf G, Markham N, Abman SH. Excess soluble vascular endothelial growth factor receptor-1 in amniotic fluid impairs lung growth in rats: linking preeclampsia with bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol. 2012;302:L36–L46.
   Google Scholar